Biotech · Public company · Boston, MA, US
Seaport Therapeutics, Inc.
Ticker SPTX · SEC CIK 0002042347
Track this companyFree. Adds Seaport Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline1
- SPT-300Phase 2 · Major Depressive Disorder (MDD)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)PHASE2 · ENROLLING_BY_INVITATION · started Sep 2, 2025ClinicalTrials.gov NCT07161700 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)PHASE2 · RECRUITING · started Jun 19, 2025ClinicalTrials.gov NCT07065240 · fetched Nov 12, 2026
SEC filings10
- 10-Q · 10-QSEC EDGAR · filed Nov 2, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 2, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 3, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 3, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Jun 8, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 8, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 4, 2026 · fetched Nov 12, 2026
- 424B4 · 424B4SEC EDGAR · filed May 1, 2026 · fetched Nov 12, 2026
- S-1/A · S-1/ASEC EDGAR · filed Apr 27, 2026 · fetched Nov 12, 2026
- S-1 · S-1SEC EDGAR · filed Apr 10, 2026 · fetched Nov 12, 2026